Sheppard Pratt - The Institute for Advanced Diagnostics and Therapeutics

Sheppard Pratt - The Institute for Advanced Diagnostics and Therapeutics is a cutting-edge health institution located in Baltimore, Maryland. Led by Chief Science Officer Dr. Scott Aaronson, the institute specializes in neurostimulation and psychopharmacology to provide innovative solutions for patients with mental health disorders. The Institute offers proven neuromodulation techniques and advanced psychopharmacology to treat difficult-to-treat illnesses such as depression. Patients have access to treatments such as Transcranial Magnetic Stimulation (TMS) and Electroconvulsive Therapy (ECT), as well as groundbreaking research in psilocybin therapy for mental health disorders. The Institute is at the forefront of integrating biological psychiatry with psychotherapy to provide personalized care for patients. With state-of-the-art facilities and a dedicated team, Sheppard Pratt is committed to improving outcomes for individuals suffering from mental health illnesses.